Skip to main content

Table 1 Patient demographics and clinical characteristics

From: Chronic opioid use following surgery for head and neck cancer patients undergoing free flap reconstruction

Clinical Characteristic Patients N = 212 (%)
Preoperative Opioid-Naïve Preoperative Opioid Use p value
Total n = 127 (60%) n = 85 (40%)  
Gender 0.046
 Male 96 (76%) 53 (62%)  
 Female 31 (24%) 32 (38%)  
Age (years) 0.8
 Mean [SD] 61.2 [13.81] 60.6 [12.66]  
 Range 19.5–89.8 23.4–86.6  
Social Habits  
 Prior Tobacco 89 (70%) 59 (69%) 1.0
 Prior Alcohol 87 (69%) 58 (68%) 0.8
Clinical Stage 0.05
 In Situ (Stage 0) 2 (2%) 1 (1%)  
 I 11 (9%) 15 (18%)  
 II 26 (20%) 13 (15%)  
 III 15 (12%) 13 (15%)  
 IV 65 (51%) 43 (51%)  
 Other 8 (6%) 0 (0%)  
Primary Tumour Location 0.04
 Oral Cavity 102 (80%) 62 (73%)  
 Salivary Gland 4 (3%) 8 (9%)  
 Paranasal Sinus 4 (3%) 8 (9%)  
 Other 17 (13%) 7 (8%)  
Free Flap 1.0
 Soft Tissue 95 (75%) 64 (75%)  
 Bone 23 (18%) 16 (19%)  
 Soft Tissue + bone 9 (7%) 5 (6%)  
Treatment 0.6
 Surgery Alone 53 (42%) 39 (46%)  
 Surgery + Adjuvant 74 (58%) 46 (54%)